The University of Hong Kong, Hong Kong, China

Prof. Loey Mak is a Clinical Assistant Professor in The School of Clinical Medicine, The University of Hong Kong. She is a specialist in gastroenterology and hepatology and a clinical researcher focusing on chronic hepatitis B infection. She has published widely in leading journals of the field, and her work has been cited in international clinical guidelines and led to advancement in development of novel drugs in clinical trials. Prof. Mak is currently an associate editor for Clinical Molecular Hepatology, Gut Science and JGH Open; editorial board member for Journal of Hepatology, Hepatology Communications and Journal of Clinical and Translational Hepatology. She has received numerous prestigious awards, highlights being the Emerging Leader Award by The European Association for Study of Liver in 2023 and The Rising Star Award (runner-up), Global Women in Healthcare Awards by the EMMS International and Royal College of Physicians of Edinburgh in 2025. She is the first Chinese woman to receive such accolade in recognition of her contribution to liver research, clinical service and medical education. Prof. Mak was elected as a Fellow by the Royal College of Physicians of London, UK in 2024. She was awarded the Croucher Fellowship in 2021 to pursue postdoctoral research in the role of hepatitis B surface antigen in chronic hepatitis B infection: Focusing on effects on peripheral and intra-hepatic lymphocyte populations, in the group led by Prof. Patrick Kennedy and Dr. Upkar Gill at the Barts Liver Centre, Blizard Institute, The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom. She was the awardee of the Universitas 21 Fellowship in 2025 and conducted a 2-month Visiting Fellowship in The Storr Liver Center, Westmead Institute of Medical Research, Sydney, Australia in 2025. Locally, she is recognised as one of the Ten Outstanding Young Persons of Hong Kong in 2024, and serves the government of Hong Kong SAR in the capacity of expert for Drug Registration of Pharmacy and Poisons Committee (PRC), and Clinical Working Group of Steering Committee on Prevention and Control of Viral Hepatitis of Department of Health. She is a Principal Investigator of in the State Key Laboratory of Liver Research in The University of Hong Kong. Prof. Mak also drives efforts to micro-elimination of hepatitis C virus in high-risk populations and values patient empowerment. She is actively involved in knowledge exchange activities locally and internationally.